
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday. The medical device company reported adjusted earnings per share of $3.35, up from $3.17 a year ago. It beat the consensus of $3.28. …